Neelufar Mozaffarian's most recent trade in Fate Therapeutics Inc was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fate Therapeutics Inc | Neelufar Mozaffarian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |